$8.53 Million is the total value of Founders Fund VI Management, LLC's 2 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ROIVANT SCIENCES LTD | $8,261,829 | -7.6% | 1,119,489 | 0.0% | 96.90% | +0.7% | ||
| AMTI | APPLIED MOLECULAR TRANS INC | $264,514 | -23.8% | 826,607 | 0.0% | 3.10% | -17.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ROIVANT SCIENCES LTD | 8 | Q3 2023 | 99.0% |
| APPLIED MOLECULAR TRANS INC | 8 | Q3 2023 | 34.0% |
| SNAP INC | 4 | Q2 2023 | 9.8% |
| OSCAR HEALTH INC | 2 | Q1 2022 | 79.6% |
View Founders Fund VI Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Founders Fund VI Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.